Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tax Cuts, Rx Debate May Stymie Medicare Coverage Reforms – Rep. Cardin

This article was originally published in The Gray Sheet

Executive Summary

Enacting tax cuts proposed by the Bush Administration could limit funding for Medicare reforms outside a prescription drug benefit, according to Rep. Ben Cardin (D-Md.)

You may also be interested in...



Medicare Reform Bills Head To Conference; Competitive Bidding Fuels Debate

AdvaMed will work closely with Sens. Rick Santorum (R-Penn.) and Blanche Lincoln (D-Ark.) to ensure language easing criteria for new technology "add-on" payments is included in the final Medicare bill

Medicare Reform Bills Head To Conference; Competitive Bidding Fuels Debate

AdvaMed will work closely with Sens. Rick Santorum (R-Penn.) and Blanche Lincoln (D-Ark.) to ensure language easing criteria for new technology "add-on" payments is included in the final Medicare bill

Clinical Trial New Device Coverage Key For Small Firms, AbioMed Exec Says

A provision authorizing Medicare to cover routine costs of clinical trials for investigational devices likely will be attached to prescription drug legislation due after lawmakers return from the Memorial Day recess June 2

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018379

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel